Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07720115 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase 2 Trial Of S-531011 With RadScopal In Previously Treated Metastatic Colorectal Cancer

Name: Phase 2 Trial Of S-531011 With RadScopal In Previously Treated Metastatic Colorectal Cancer — clinical trial record (NCT07720115)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusWithdrawn

PhasePhase 2

SponsorM.D. Anderson Cancer Center

Started2026-08-12

View on ClinicalTrials.gov ↗

Amendment history

2026-09-09

Study Status, Study Design, Contacts/Locations v2

Withdrawn before enrolling

Trial withdrawn: 0 participants

Primary completion moved earlier: 2029-01-01 → 2026-09-04

Completion moved earlier: 2031-01-01 → 2026-09-04

Start dateestimated 2027-01-07→confirmed 2026-08-12

Enrollment targetestimated 30→confirmed 0

Study sites1→0

2026-07-23

Study Status, Sponsor/Collaborators v1

Collaborators-13 characters

~~Shionogi Inc.~~

2026-07-17

Original filing

M.D. Anderson Cancer Center

1,223 trials monitored

See 78 trials at risk

Colorectal Cancer

2,904 trials monitored

See 127 trials at risk

To learn if the experimental drug S-531011 plus RadScopalTM radiation therapy can help to control previously treated metastatic colorectal cancer.

Trial Details

NCT Number	NCT07720115
Lead Sponsor	M.D. Anderson Cancer Center
Conditions	Phase II, S-531011, RadScopal, Metastatic Colorectal Cancer
Start Date	2026-08-12
Primary Completion	2026-09-04 (estimated)
Study Completion	2026-09-04 (estimated)
Updated on ClinicalTrials.gov	2026-09-11